TCL played a key role on the Executive Committee; guiding this case on behalf of direct purchasers of Lidoderm, who alleged that the defendants conspired to delay the launch of less expensive versions of lidocaine patches. Along with our co-counsel, we recovered a $166 million settlement on the eve of trial.